腹腔积液

fù qiānɡ jī yè
  • Ascites;abdominal dropsy
腹腔积液腹腔积液
  1. 彩超对乳腺良、恶性肿瘤的鉴别诊断CT在良恶性腹腔积液性质鉴别中的应用

    Color Doppler ultrasound of the Breast in the Differential Diagnosis of Benign and Malignant Tumor

  2. 腹腔积液的CT值。

    The value of seroperitoneum CT .

  3. 目的:研究对良、恶性腹腔积液有鉴别意义的CT征象。

    Objective : To evaluate the sign CT which are significative to distinguish the benign seroperitoneum and the malignant .

  4. 电离辐射对小鼠腹腔积液型S180细胞凋亡的影响

    The influence of radiation to the S180 cell of mice

  5. 中心静脉导管引流联合IL-2和甘露聚糖肽治疗恶性胸腹腔积液

    Intracavitary perfusion of interleukin-2 or mannosazone through implanted central venous catheter for treatment of malignant pleural and peritoneal effusion

  6. Calretinin、CEA标记在胸腹腔积液细胞学诊断中的应用

    Application of calretinin and CEA immunocytochemical label in serous effusion cytology

  7. 结论直接淋巴管造影和造影后CT成像可为合并乳糜性胸、腹腔积液的LAM的诊断和治疗提供重要依据。

    Conclusion Direct lymphangiography and subsequent CT imaging can provide important evidence for diagnosis and therapy of LAM combined with celiac pleural fluid and ascites .

  8. 目的:用流式细胞仪对胸腹腔积液患者同一次胸腹水细胞进行DNA含量测定,并与胸腹水脱落细胞学检查进行对比分析。

    Objective : The same sample that the cell of hydrothorax and ascites was tested for DNA content by Flow cytometry ( FCM ), the results were compared with the method of exfoliative cytology .

  9. B超引导下经皮穿刺置CVP管引流局限性腹腔积液的临床研究

    Drainage of Local Fluid Accumulation in Abdomen through CVP Catheter Guided by B Ultrasound

  10. 结果:恶性组患者胸腹腔积液标本中pH、CEA值较结核性胸膜炎组和非特异性炎症组明显升高(P<0.05);

    Results pH and CEA values in the samples with malignant tumor was remarkably increased compared with tuberculous or chronic nonspecific inflammation ( P < 0.05 ) .

  11. 目的探讨顺铂(DDP)联合生物反应调节剂(BRM)治疗恶性胸腹腔积液的疗效。

    Objective Toe value the effect of intracavity treatment with DDP and BRM for malignant pleural effusions or ascites .

  12. TNP-470抑制小鼠恶性腹腔积液形成的实验研究

    An experimental study of angiogenesis inhibitor TNP-470 on the formation of malignant ascites in mice

  13. 方法针对重症急性胰腺炎合并腹腔积液的早期病理发展特点,对18例SAP患者早期采用经腹腔镜腹腔灌洗引流、胰包膜切开。

    Methods To counteract the early pathological course of SAP , peritoneal lavage , drainage and pancreatic envelope incision through laparoscope were applied on 18 cases of patients with SAP .

  14. 目的探讨血清和腹腔积液中肿瘤标志物SA、CEA和SF联检对诊断肝癌的临床价值。

    Objective To study the clinical value of combined determination of SA , CEA and SF levels in serum and abdominis effusion fluids for diagnosis of liver cancer .

  15. 肝硬化有腹腔积液组患者NO、ET含量明显高于对照组(P<0.01)和无腹腔积液组(P<0.05)。

    The plasma levels of NO and ET were significantly higher in ascites patients than those in the controls ( P < 0.01 ) and the no ascites patients ( P < 0.05 ) .

  16. 方法选择肝硬化患者58例(其中腹腔积液患者42例)、正常对照32例,用放射免疫法检测其血浆CGRP和ET-1含量。

    Methods The plasma levels of CGRP and ET-1 were measured in 58 patients with cirrhosis ( 42 cases with ascites ) and 32 normal controls by radioimmunoassay .

  17. 弥漫性摄取见于四肢、胸、腹部(淋巴和B或静脉回流障碍120例,恶性胸、腹腔积液各146及44例,甲状旁腺功能亢进3例,肝脏转移瘤20例);

    Diffuse accumulations were detected in limbs , chest and abdomen ( malignant pleural effusion , 146 , malignant seroperitoneum , 44 , obstruction in circumfluence of vein or lymph , 120 , hyperparathyroidism , 3 , metastatic tumor in liver , 20 ) .

  18. 结论DDP联合BRM治疗恶性胸腹腔积液疗效肯定,是1种较好的治疗方法。

    Conclusion The intracavity with DDP and BRM in the treatment malignant pleural effusions or ascites has a good and sure effect .

  19. 方法采用Seldinger技术对37例外伤性脾破裂行明胶海绵颗粒栓塞部分脾动脉止血,右下腹麦氏点经皮穿刺放置导管引流腹腔积液。

    Methods 37 patients with spleen rupture were performed with partial splenic embolization ( PSE ) by Seldinger 's methods .

  20. 结果8例患者MSCT检查均显示不同程度的腹腔积液,肠系膜周边脂肪密度增高,肠系膜上静脉增宽。

    Of them , one case was undergone operation . Results MSCT findings included different extent of ascites , raised mesenteric fat density and the superior mesenteric vein widened .

  21. 结论LC术后胆囊管瘘临床表现多样,B超可以发现腹腔积液,确定诊断依赖于MRCP和ERCP。

    Conclusions The clinical manifestations of cystic duct fistula were different . Ascites can be found under B ultrasound . Final diagnosis relies on MRCP and / or ERCP .

  22. 方法134例胸腹腔积液采用黏蛋白定性(即Rivalta试验)、SG与免疫比浊法测定积液及血清中CRP水平,进行比对。

    Methods Serosamucin ( Rivalta test ) and SG were determined protein in 134 samples ( hydrothorax or ascites ) and compared with CRP determined by nephelometric immunoassay in 34 hydrothorax or ascites and sera .

  23. 目的:对比观察人胎肝细胞和胎牛肝细胞低分子天然抑瘤物(LMW-NTS)对小鼠腹腔积液型S-180细胞生长的抑制效应。

    Objective : Effect of the low molecular weight natural tumor suppressor ( LMW NTS ) of human fetal hepatocyte and that of embryo calf hepatocyte on the growth of murine S 180 cells was observed .

  24. 良、恶性胸腹腔积液NMP22的阳性率分别为94.0%(29/31)和8.0%(1/12)。

    The positive rates of NMP 22 in malignant and benign group of thoracic and abdominal cavity dropsy were 94 % ( 29 / 31 ) and 8 % ( 1 / 12 ), respectively .

  25. 白细胞介素Ⅱ联合加温化疗治疗癌性腹腔积液

    Treatment of cancerous ascites with infusion of IL 2 plus warmed medicine

  26. 闭式引流及香菇多糖腔内灌注治疗恶性胸腹腔积液临床观察

    Close drainage and intracavity perfusion of lentinan for treatment of malignant pleural-peritoneal effusion

  27. 化疗联合腔内注射沙培林治疗恶性胸腹腔积液的临床评价

    Systematic Chemotherapy Combined with Picibanil Intracavity in the Treatment for Hydrothorax and Ascites

  28. 磁富集法检测52例胸腹腔积液中癌细胞的结果分析

    52 Detections of Cancer Cells from Peritoneal and Pleural Fluid Using Magnetic Enrichment Method

  29. 免疫组织化学染色在妇科盆腹腔积液细胞学诊断中的应用

    Application of immunohistochemistry for cytological diagnosis in the gynecological pelvic and peritoneal cavity fluids

  30. 自体癌性胸腹腔积液蛋白质回输临床疗效观察

    Study of clinical therapeutic effectiveness of infusing auto-protein isolated from malignant hydrothorax and ascites